Dosage, plasms concentration and antiarrhythmic effect of procainamide in sustained-release tablets. 1974

M Arstila, and M Katila, and H Sundquist, and M Anttila, and E Pere, and R Tikkanen

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011342 Procainamide A class Ia antiarrhythmic drug that is structurally-related to PROCAINE. Procaine Amide,Apo-Procainamide,Biocoryl,Novocainamide,Novocamid,Procainamide Hydrochloride,Procamide,Procan,Procan SR,Procanbid,Pronestyl,Rhythmin,Amide, Procaine,Hydrochloride, Procainamide
D011343 Procaine A local anesthetic of the ester type that has a slow onset and a short duration of action. It is mainly used for infiltration anesthesia, peripheral nerve block, and spinal block. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1016). Anuject,Geriocaine,Gerokit,Hewedolor-Procain,Lophakomp-Procain N,Novocain,Novocaine,Procain Braun,Procain Jenapharm,Procain Rödler,Procain Steigerwald,Procain curasan,Procaina Serra,Procaine Hydrochloride,Pröcaine chlorhydrate Lavoisier,Röwo Procain,procain-loges,Hydrochloride, Procaine
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D003692 Delayed-Action Preparations Dosage forms of a drug that act over a period of time by controlled-release processes or technology. Controlled Release Formulation,Controlled-Release Formulation,Controlled-Release Preparation,Delayed-Action Preparation,Depot Preparation,Depot Preparations,Extended Release Formulation,Extended Release Preparation,Prolonged-Action Preparation,Prolonged-Action Preparations,Sustained Release Formulation,Sustained-Release Preparation,Sustained-Release Preparations,Timed-Release Preparation,Timed-Release Preparations,Controlled-Release Formulations,Controlled-Release Preparations,Extended Release Formulations,Extended Release Preparations,Slow Release Formulation,Sustained Release Formulations,Controlled Release Formulations,Controlled Release Preparation,Controlled Release Preparations,Delayed Action Preparation,Delayed Action Preparations,Formulation, Controlled Release,Formulations, Controlled Release,Prolonged Action Preparation,Release Formulation, Controlled,Release Formulations, Controlled,Sustained Release Preparation,Timed Release Preparation,Timed Release Preparations
D005260 Female Females
D006207 Half-Life The time it takes for a substance (drug, radioactive nuclide, or other) to lose half of its pharmacologic, physiologic, or radiologic activity. Halflife,Half Life,Half-Lifes,Halflifes
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000284 Administration, Oral The giving of drugs, chemicals, or other substances by mouth. Drug Administration, Oral,Administration, Oral Drug,Oral Administration,Oral Drug Administration,Administrations, Oral,Administrations, Oral Drug,Drug Administrations, Oral,Oral Administrations,Oral Drug Administrations

Related Publications

M Arstila, and M Katila, and H Sundquist, and M Anttila, and E Pere, and R Tikkanen
October 1985, Southern medical journal,
M Arstila, and M Katila, and H Sundquist, and M Anttila, and E Pere, and R Tikkanen
September 1976, Ugeskrift for laeger,
M Arstila, and M Katila, and H Sundquist, and M Anttila, and E Pere, and R Tikkanen
January 1990, The Canadian journal of cardiology,
M Arstila, and M Katila, and H Sundquist, and M Anttila, and E Pere, and R Tikkanen
March 1975, Current therapeutic research, clinical and experimental,
M Arstila, and M Katila, and H Sundquist, and M Anttila, and E Pere, and R Tikkanen
September 1984, Annals of internal medicine,
M Arstila, and M Katila, and H Sundquist, and M Anttila, and E Pere, and R Tikkanen
June 1984, Drug intelligence & clinical pharmacy,
M Arstila, and M Katila, and H Sundquist, and M Anttila, and E Pere, and R Tikkanen
February 1998, Therapeutic drug monitoring,
M Arstila, and M Katila, and H Sundquist, and M Anttila, and E Pere, and R Tikkanen
April 1985, Archives of internal medicine,
M Arstila, and M Katila, and H Sundquist, and M Anttila, and E Pere, and R Tikkanen
November 1977, The Medical journal of Australia,
M Arstila, and M Katila, and H Sundquist, and M Anttila, and E Pere, and R Tikkanen
November 1984, Canadian Medical Association journal,
Copied contents to your clipboard!